End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
This report contains market size and forecasts of End Stage Renal Disease (ESRD) Therapy in Global, including the following market information:
Global End Stage Renal Disease (ESRD) Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global End Stage Renal Disease (ESRD) Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hemodialysis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of End Stage Renal Disease (ESRD) Therapy include Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO and Newsol, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the End Stage Renal Disease (ESRD) Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global End Stage Renal Disease (ESRD) Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global End Stage Renal Disease (ESRD) Therapy Market Segment Percentages, by Type, 2021 (%)
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Global End Stage Renal Disease (ESRD) Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global End Stage Renal Disease (ESRD) Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Kidney Dialysis Centers
At Homes
Others
Global End Stage Renal Disease (ESRD) Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global End Stage Renal Disease (ESRD) Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies End Stage Renal Disease (ESRD) Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies End Stage Renal Disease (ESRD) Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical